Suppr超能文献

垂体腺瘤切除术后最初 1 年随访失访风险最高的患者。

Patients at Greatest Risk of Missing Initial 1-Year Follow-Up After Pituitary Adenoma Resection.

机构信息

Department of Neurological Surgery, Loyola University Medical Center, Maywood, Illinois, USA.

Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.

出版信息

World Neurosurg. 2024 Sep;189:e1092-e1097. doi: 10.1016/j.wneu.2024.07.091. Epub 2024 Jul 18.

Abstract

OBJECTIVE

Routine evaluation and surveillance imaging after pituitary adenoma (PA) endoscopic endonasal transsphenoidal resection (EETS) is a neurosurgical practice to identify tumor recurrence. This study aims to identify social and clinical factors that may contribute to patients missing their initial 1-year follow-up appointment and provide guidance for targeted education to improve patient adherence with postoperative treatment plans, ultimately reducing unknown adenoma recurrence.

METHODS

The authors performed a single-center retrospective review of patients who underwent EETS for PAs from 2007 to 2023. Patients were analyzed for sociodemographic factors, presenting symptoms, time to surgery, surgical outcomes, and adherence to postoperative follow-up visits at 1 year after surgery.

RESULTS

A total of 256 patients with PAs treated by EETS met inclusion criteria; 218 (85%) of these patients attended 1-year follow-up, and 38 (15%) missed this visit. Twenty-nine (76%) individuals who missed their 1-year follow up were men (P = 0.006). Divorced/widowed/separated patients were 2 times more likely to miss their follow-up compared with their married counterparts (P = 0.008). Additional significant risk factors included older age, as the mean age for patients who missed their 1-year appointment was 60.1 years compared with 54.7 years (P = 0.028). Patients with visual field deficits at initial presentation were also less likely to follow-up at 1 year (P = 0.03).

CONCLUSIONS

Risk factors of missed 1-year follow-up appointments after PA resection include male sex, divorced/widowed/separated marital status, older age, and the presence of visual deficits at initial presentation. Increased education efforts can be selectively aimed at these at-risk patient cohorts to improve patient compliance and reduce consequences of undetected tumor recurrence.

摘要

目的

垂体腺瘤(PA)内镜经鼻蝶窦入路切除术(EETS)后进行常规评估和随访影像学检查是识别肿瘤复发的神经外科实践。本研究旨在确定可能导致患者错过初始 1 年随访预约的社会和临床因素,并为有针对性的教育提供指导,以提高患者对术后治疗计划的依从性,最终减少未知的腺瘤复发。

方法

作者对 2007 年至 2023 年间接受 EETS 治疗的 PA 患者进行了单中心回顾性研究。分析了患者的社会人口统计学因素、临床表现、手术时间、手术结果以及术后 1 年随访的依从性。

结果

共有 256 例接受 EETS 治疗的 PA 患者符合纳入标准;其中 218 例(85%)患者接受了 1 年随访,38 例(15%)患者错过了这次随访。29 例(76%)错过 1 年随访的患者为男性(P=0.006)。与已婚患者相比,离婚/丧偶/分居的患者错过随访的可能性高 2 倍(P=0.008)。其他显著的危险因素包括年龄较大,错过 1 年预约的患者平均年龄为 60.1 岁,而 54.7 岁(P=0.028)。初次就诊时存在视野缺损的患者在 1 年时也不太可能进行随访(P=0.03)。

结论

PA 切除术后错过 1 年随访预约的危险因素包括男性、离婚/丧偶/分居的婚姻状况、年龄较大和初次就诊时存在视觉缺陷。可以有针对性地向这些高风险患者群体增加教育力度,以提高患者的依从性,减少未发现肿瘤复发的后果。

相似文献

1
Patients at Greatest Risk of Missing Initial 1-Year Follow-Up After Pituitary Adenoma Resection.
World Neurosurg. 2024 Sep;189:e1092-e1097. doi: 10.1016/j.wneu.2024.07.091. Epub 2024 Jul 18.
2
Incarceration and emergency department visit frequency as predictors for missing day of cataract surgery at County hospital.
J Med Access. 2025 Jul 24;9:27550834251359809. doi: 10.1177/27550834251359809. eCollection 2025 Jan-Dec.
4
Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas in Patients Presenting With Monocular Blindness.
Oper Neurosurg (Hagerstown). 2024 Sep 1;27(3):265-278. doi: 10.1227/ons.0000000000001116. Epub 2024 Apr 10.
6
Surgical outcomes and follow-up results of 53 pediatric craniopharyngioma cases: a single-center study.
J Neurosurg Pediatr. 2023 Dec 29;33(3):223-235. doi: 10.3171/2023.10.PEDS23293. Print 2024 Mar 1.
7
Clinical and Operative Risk Factors Associated With Prolonged Length of Stay After Endoscopic Pituitary Adenoma Resection.
Neurosurgery. 2024 Aug 1;95(2):392-399. doi: 10.1227/neu.0000000000002890. Epub 2024 Feb 29.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

引用本文的文献

本文引用的文献

2
Evaluation of Retrospective Patient Preference on Extent of Resection of Nonfunctioning Pituitary Adenomas.
World Neurosurg. 2024 Feb;182:e98-e106. doi: 10.1016/j.wneu.2023.11.053. Epub 2023 Nov 22.
4
Remission, complications, and overall survival in transsphenoidal pituitary surgery-a Swedish single-center experience of 578 patients.
Acta Neurochir (Wien). 2023 Mar;165(3):685-692. doi: 10.1007/s00701-022-05456-8. Epub 2023 Jan 20.
5
Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.
Diagnostics (Basel). 2022 Apr 13;12(4):977. doi: 10.3390/diagnostics12040977.
7
Which patients miss appointments with general practice and the reasons why: a systematic review.
Br J Gen Pract. 2021 May 27;71(707):e406-e412. doi: 10.3399/BJGP.2020.1017. Print 2021 Jun.
8
Factors Associated with Increased Risk of Patient No-Show in Telehealth and Traditional Surgery Clinics.
J Am Coll Surg. 2020 Dec;231(6):695-702. doi: 10.1016/j.jamcollsurg.2020.08.760. Epub 2020 Sep 3.
9
Perioperative management of endoscopic transsphenoidal pituitary surgery.
World J Otorhinolaryngol Head Neck Surg. 2020 Mar 20;6(2):84-93. doi: 10.1016/j.wjorl.2020.01.005. eCollection 2020 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验